Why choose PrenatalSafe for a NIPT test ?
QUALITY: PROVEN PERFORMANCE
- Latest generation CE-IVD technology
- Proprietary NIPT FLOW™ algorithm
- Sensitivity and specificity >99% (validated on 71,740 pregnancies)
Performance table:
|
Disease
|
Sensitivity
|
Specificity
|
|
Trisomy 21
|
99.54%
|
99.92%
|
|
Trisomy 18
|
100%
|
99.97%
|
|
Trisomy 13
|
100%
|
99.99%
|
|
Monosomy X (Turner)
|
98.11%
|
99.98%
|
|
XXX, XXY, XYY
|
100%
|
100%
|
|
Rare Autosomal Aneuploidies
|
100%
|
100%
|
|
Microdeletions
|
83.33%
|
99.99%
|
HIGH SAMPLE VALIDATION
- 70,000 samples analyzed for common trisomies
- 65,000 samples for sex chromosome aneuploidies
- 40,000 samples for other abnormalities
GENETICS SERVING CLINICAL PRACTICE
- UNI EN ISO 15189:2013 accreditation
- CE-IVD NIPT FLOW™ algorithm
- Illumina CE-IVD technology
- Authorized logistics for UN3373 biological samples
- Full sample traceability
- Comprehensive insurance protection
